The forecast for the import of streptomycins to France from 2024 to 2028 shows a steady decline from 63.74 to 57.83 thousand kilograms. With a consistent year-on-year decrease, the compound annual growth rate (CAGR) over the forecast period indicates a shrinking demand. Notably, the year-on-year decline is approximately around 2%.

Future Trends to Watch For:

Changes in domestic production capacities for streptomycins in France could further impact import volumes.
Shifts in global health policies and antibiotic use guidelines may alter demand dynamics.
Developments in biotechnology and emerging treatments could potentially reduce reliance on imported antibiotics like streptomycins.
Economic fluctuations and international trade relations could influence import pricing and volume.